The Corrona Psoriatic Arthritis and Spondyloarthritis (PsA-SpA) Registry

Sponsor
CorEvitas
Study ID
NCT02530268
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This prospective, non-interventional, research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for PsA-SpA in a cohort of patients cared for by rheumatologists across North America. Secondary objectives include analyzing the epidemiology and natural history of the disease, its comorbidities, and current treatment practices.

Key Dates

First listed
Aug 21, 2015
Start date
Mar 31, 2013
Status verified
Jan 2026
Primary completion
Dec 31, 2100
Completion
Dec 31, 2100

Study Design

Enrollment
5,000 participants (estimated)

Arms

  • Arm: Ankylosing Spondylitis
    Pts presenting to enrolling sites across the US are invited to enroll if eligible
  • Arm: Psoriatic Arthritis
    Pts presenting to enrolling sites across the US are invited to enroll if eligible

Primary Outcome Measure

The major clinical outcomes include an assessment of the epidemiology of Spondyloarthritis; to better understand the presentation, natural history, management and outcomes. [ Time Frame: A minimum of 10 years from last patient enrolled ]

Find similar trials

Nationwide
Psoriatic arthritis trialsRheumatology trialsAutoimmune disease trialsMusculoskeletal disorders trials

Related Studies